Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Perspective Therapeutics (CATX) FCF Margin (2016 - 2025)

Perspective Therapeutics (CATX) has disclosed FCF Margin for 16 consecutive years, with 81514.29% as the latest value for Q4 2025.

  • Quarterly FCF Margin rose 9019637.0% to 81514.29% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 16263.58% through Dec 2025, down 1495732.0% year-over-year, with the annual reading at 16263.58% for FY2025, 1495732.0% down from the prior year.
  • FCF Margin hit 81514.29% in Q4 2025 for Perspective Therapeutics, up from 16611.81% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 81514.29% in Q4 2025 to a low of 16611.81% in Q3 2025.
  • Historically, FCF Margin has averaged 2164.57% across 5 years, with a median of 142.7% in 2022.
  • Biggest YoY gain for FCF Margin was 9019637bps in 2025; the steepest drop was -2108814bps in 2025.
  • Year by year, FCF Margin stood at 98.26% in 2021, then plummeted by -210bps to 107.92% in 2022, then surged by 345bps to 264.44% in 2023, then tumbled by -3383bps to 8682.08% in 2024, then skyrocketed by 1039bps to 81514.29% in 2025.
  • Business Quant data shows FCF Margin for CATX at 81514.29% in Q4 2025, 16611.81% in Q3 2025, and 8971.93% in Q2 2025.